Bristol Myers Squibb and SystImmune announce phase 3 results for antibody-drug conjugate
The drug showed improvements in overall survival and progression-free survival in two cancers
- News
- Research
- Sales
- Regulatory
- Healthcare
- Marketing
Bristol Myers Squibb and SystImmune announce phase 3 results for antibody-drug conjugate
The drug showed improvements in overall survival and progression-free survival in two cancers
Lilly to acquire LimmaTech Biologics and Vaccine Company in deals totalling $2.33bn
The acquisitions reinforce the company’s commitment to reduce the long-term burden of serious disease
NICE recommends Genmab’s Tivdak for recurrent or metastatic cervical cancer
It is estimated that 3,300 women are diagnosed with cervical cancer in the UK each year
EMA celebrates diversity and inclusion in science and healthcare
The EU body underlines its commitment to diverse perspectives in medicines regulation
PMEA welcome Simon Bates as new Chair of the judging panel
Roche and Alnylam share their experiences entering the PMEAs
Latest content
VML Health appoints Jason Graff as Global CCO
Graff joins VML Health from AREA 23 New York
Read More
Gates Medical Research Institute appoints Charles Wells as Chief Medical Officer and Head of Medical Development
Wells previously served in executive leadership roles at Sanofi and Evotec
Read More
Delphia Therapeutics appoints David Kerstein as Chief Medical Officer
Kerstein was most recently CMO of IDRx, a company acquired by GSK in 2025
Read More
The blind spot undermining pharma product launches – and how to eliminate it
Something critical is missing: a clear view of what’s actually happening on the ground
Read More
Intelligence
The digital age and the advance of AI – pushing communications to new heights
As new comms excellence opportunities abound, staying connected through core messaging remains critical
Read More
GenAI: embracing the transformation – with caution
Despite the GenAI fervour, there is an acute need to prepare organisations to understand which specific tools they need and how to use them
Read More
The race to explore and harness GenAI in healthcare
AI has graduated from being a procurer of efficiencies to seemingly an enabler of unimagined possibilities
Read More
Communication breakdown
Why soft skills are more important than ever in life sciences
Read More
Medicine shortages strike again – can radio-frequency identification technology help?
RFID has emerged as a key technology for its rapid, accurate data capture, and track and trace capabilities for manufacturing and supply chain operations
Read More
Pandemic readiness is now a financial risk test – and the UK must treat it that way
COVID-19 showed how quickly a health emergency becomes a fiscal event: disrupting supply chains, reshaping capital allocation and exposing governance weaknesses
Read More
Blogs
Latest
Medscape Education Brings AI to the Hematology Frontline at EHA 2026
June 2, 2026 | Medscape Education|AI, EHA, EHACongress26, Symposia, heamatology, hematology
Medscape Education is supporting a dedicated AI symposium at the 2026 European Hematology Association (EHA) Annual Congress in Stockholm on June 11, 2026.
What do HCPs want from pharma medical information sites in 2026?
May 29, 2026 | Graphite Digital|HCP engagement, digital experience, medical, pharma medical, web design
At Graphite, we regularly carry out first-hand research with healthcare professionals (HCPs) to understand how they interact with digital experiences in practice. When you combine …
The Ripple Effect: Why Connection is the Heart of Healthcare Leadership
May 28, 2026 | Medscape Education|#WomenInHealthcare #Leadership #MedEd
In the fast-paced environment of clinical medicine, it is easy to focus solely on data and outcomes. However, as Dr. Toyin Nwafor (Gilead Sciences) and …
The hidden work of turning breakthroughs into outcomes
May 28, 2026 | Mednet|Making Health Whole, healthcare communications, med comms
The “problem” in healthcare comms is rarely what you say, it’s whether people can act on it. This article explains how we design whole-person engagement …
Cuttsy+Cuttsy launches a practical roadmap to enhance clinical trial participant experience
May 21, 2026 | Cuttsy + Cuttsy|clinical trials
Cuttsy+Cuttsy has launched The Experience Gap, a practical roadmap designed to help clinical trial teams improve participant engagement, support and retention across the full study …
From activity to impact: 5 takeaways from MAPS Americas 2026
June 2, 2026 | Inizio|
Across sessions, panels, and conversations on the ground in Denver, there was a noticeable shift in both mindset and momentum. Many of the themes discussed …
Where it all began – why we developed The Experience Gap
June 1, 2026 | Cuttsy + Cuttsy|Participant engagement, clinical trials, communication
Learn how The Experience Gap was developed to help sponsors, CROs and site teams improve clinical trial participation by identifying friction points, enhancing patient experience, …
Inizio launches Intelligent Congress: Turning medical event investment into measurable impact
May 12, 2026 | Inizio|
Inizio, the global commercialization partner to the health and life sciences industry, today announced the launch of Intelligent Congress – a connected, end-to-end solution designed …
Strategies to enhance the provider and patient EAP experience
April 30, 2026 | Uniphar|
Expanded access programs (EAPs) play a multifaceted role in the drug development life cycle, serving as a critical bridge between clinical trials and commercial availability.